Financhill
Back

Xeris Biopharma Holdings Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
88

XERS
Xeris Biopharma Holdings

Last Price:
3.34
Seasonality Move:
0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Xeris Biopharma Holdings Stock Forecast

  • Is Xeris Biopharma Holdings Stock Undervalued?
    The current Xeris Biopharma Holdings [XERS] share price is $3.34. The Score for XERS is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
  • XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Xeris Biopharma Holdings Stock Go Up Next Year?

Data Unavailable

Xeris Biopharma Holdings Stock Rating

Data Unavailable

Xeris Biopharma Holdings Stock Price History

Is XERS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
xerispharma.com

52-Week Data

52-Week High:
3.39
52-Week Low:
1.46

Prediction Charts

Market Cap:
497.66M
Price in USD:
3.34
Volume:
2.22M
Beta:
1.46

Technical Analysis

SMA50:
2.94
SMA100:
2.67
SMA200:
2.47
52-Wk Change:
80.54%

Stock Predictions

  • Is Xeris Biopharma Holdings stock public?
    Yes, Xeris Biopharma Holdings is a publicly traded company.
  • What is the Xeris Biopharma Holdings stock quote today?
    The Xeris Biopharma Holdings stock price is 3.34 USD today.
  • How to buy Xeris Biopharma Holdings stock online?
    You can buy Xeris Biopharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-18 3.04 3.06 3.12 3.03
Oct-21 3.04 3.03 3.09 2.98
Oct-22 3.00 3.02 3.09 2.98
Oct-23 2.99 3.11 3.12 2.96
Oct-24 3.10 3.24 3.27 3.08
Oct-25 3.25 3.20 3.39 3.20
Oct-28 3.25 3.23 3.35 3.21
Oct-29 3.21 3.23 3.25 3.15
Oct-30 3.25 3.23 3.31 3.19
Oct-31 3.22 3.22 3.29 3.10
Nov-1 3.26 3.23 3.29 3.17
Nov-4 3.20 3.22 3.32 3.13
Nov-5 3.25 3.26 3.28 3.10
Nov-6 3.31 3.34 3.39 3.25

Xeris Biopharma Holdings Earnings

Data Unavailable

Xeris Biopharma Holdings Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.15 per share.

* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.